He also suggested patients be proactive. ‘I would encourage patients to possess a dialogue with their doctor about the advantages of cardiac rehab after hospitalization for a heart-related event,’ O’Gara said. During that speak, he added, patients should talk about any obstacles they can face in sticking with a program. ‘As physicians, we need to make it as simple as possible for our patients to wait and complete a cardiac rehab program,’ O’Gara said.. Too Few Heart Attack Patients Get Cardiac Rehab, Study Finds: – WEDNESDAY, Aug.Related StoriesDiscovery may open up new doors to focusing on how melanoma grows and spreadsNew results reveal association between colorectal cancers and melanoma drug treatmentStudy looks at survival benefits of medical resection for melanoma individuals with abdominal metastasesIn this latest analysis, the 352 individuals randomly assigned to get the BRAF inhibitor dabrafenib plus the MEK inhibitor trametinib acquired a median OS of 25.6 months. This was not merely significantly longer compared to the 18. And after a median follow-up of 19 weeks, the 2-yr survival rate was significantly higher for the dabrafenib plus trametinib group than for the vemurafenib group, at 51 percent versus 38 percent. Median PFS was also significantly longer, with corresponding moments of 12.6 and 7.3 months, and overall response rate and duration of response were similarly improved in the dual therapy compared with the monotherapy arm, at 66 percent versus 53 percent and 13.8 versus 8.5 months, respectively.